Floatz logo

Therapeutic Asset Ratings

622 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Tak-500
Breast Cancer
TakedaP1/2CC (40)
Ter-2013
Breast Cancer
Terremoto Biosciences Inc.P1/2CC (40)
Tersolisib
Breast Cancer
Eli Lilly and CompanyP1/2CC (40)
tng348
Breast Cancer
Tango Therapeutics, Inc.P1/2CC (40)
TQB3912
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P1/2CC (40)
Tuvusertib
Breast Cancer
Institut Paoli-CalmettesP1/2CC (40)
Vio-01
Breast Cancer
Valerio TherapeuticsP1/2CC (40)
Vofatamab
Breast Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
XS-02
Breast Cancer
NovaOnco Therapeutics Co., Ltd.P1/2CC (40)
2-CYCLOHEXEN-1-ONE, 6-(BENZOYLOXY)-6-((BENZOYLOXY)METHYL)-2-HYDR
Breast Cancer
Oriplantee Company LimitedP1C (39)
[68ga]ga-oncofap administration
Breast Cancer
Philogen S.p.A.P1C (39)
art4215
Breast Cancer
Artios Pharma LtdP1C (39)
Axitinib
Breast Cancer
Lynkcell EuropeP1C (39)
Bgb-43395
Breast Cancer
BeOne MedicinesP1C (39)
Cnsi-Fe
Breast Cancer
Sichuan Enray Pharmaceutical Sciences CompanyP1C (39)
Herclon
Breast Cancer
Incepta Pharmaceuticals LtdP1C (39)
ISO-1 F-18
Breast Cancer
University of PennsylvaniaP1C (39)
Mammaglobin-A Dna Vaccine
Breast Cancer
Washington University School of MedicineP1C (39)
Orialpha
Breast Cancer
Oriplantee Company LimitedP1C (39)
prt3645
Breast Cancer
Prelude TherapeuticsP1C (39)
Rly-5836
Breast Cancer
Relay Therapeutics, Inc.P1C (39)
rp903
Breast Cancer
Risen (Suzhou) Pharma Tech Co., Ltd.P1C (39)
Srg-514
Breast Cancer
SURGE TherapeuticsP1C (39)
Zn-C3
Breast Cancer
Filipa Lynce, MDP1C (39)
sm-88
Breast Cancer
Tyme, IncP2C (38)
Showing 426 to 450 of 622 assets
PreviousPage 18 of 25Next